论文部分内容阅读
目的观察以低分子肝素为主联合治疗术后下肢深静脉血栓疗效。方法采用低分子肝素联合尿激酶、巴曲酶、华法林等治疗下肢深静脉血栓形成23例。定期查血凝常规、TT、APTT,监测凝血酶时间和纤维蛋白原含量。治疗前后检查B超了解血栓表现和患肢水肿消退情况。结果在治疗后1周内19例患肢水肿消退,4例延迟至12d完全消退,肢体后周径缩小40%;B超显示下肢静脉血流通畅19例,13例患者仍可见血管内部分血流充盈缺损(<50%)。结论以低分子肝素为主联合治疗下肢深静脉血栓疗效较好,值得推广。
Objective To observe the therapeutic effect of low molecular weight heparin on postoperative deep vein thrombosis. Methods Low molecular weight heparin combined with urokinase, batroxobin, warfarin and other treatment of deep venous thrombosis in 23 cases. Regular check blood coagulation routine, TT, APTT, monitoring of thrombin time and fibrinogen content. Before and after treatment to check the B-thrombosis and limb edema understand the situation subsided. Results The edema of 19 affected limbs subsided within 1 week after treatment, 4 cases delayed to 12 days and disappeared completely, and the posterior limb circumference reduced 40%. B-mode showed venous blood flow of lower extremities was clear in 19 cases, and 13 cases were still visible blood vessels Flow filling defect (<50%). Conclusion Low molecular weight heparin-based combination therapy of deep venous thrombosis lower limb is better, it is worth promoting.